Universitätsklinikum Regensburg

[Not Available]. (2024) Berg T, Aehling NF, Bruns T, Welker MW, Weismüller T, Trebicka J, Tacke F, et al. Journal article Systematizing the risk management process in clinical radiotherapy practice: Recommendations of the working group on risk management of the DGMP (2024) Kornek D, Hoinkis C, Milickovic N, Lange A, Knak A, März M, Möller ML, Buchgeister M Journal article Understanding dental pulp inflammation: from signaling to structure. (2024) Pohl S, Akamp T, Smeda M, Uderhardt S, Besold D, Krastl G, Galler KM, et al. Journal article, Review article Development and validation of a cost-effective DIY simulation model for McDonald cerclage training (2024) Buechel J, Kalisz A, Herbert SL, Scherer-Quenzer A, Blau-Schneider B, Starrach T, Kraft K, et al. Journal article Intercellular nanotube-mediated mitochondrial transfer enhances T cell metabolic fitness and antitumor efficacy (2024) Baldwin JG, Heuser-Loy C, Saha T, Schelker R, Slavkovic-Lukic D, Strieder N, Hernandez-Lopez I, et al. Journal article Timing of veno-arterial extracorporeal membrane oxygenation support in patients with cardiogenic shock (2024) Sundermeyer J, Kellner C, Beer BN, Dettling A, Besch L, Blankenberg S, Eitel I, et al. Journal article Pre-existing parasympathetic dominance seems to cause persistent heart rate slowing after 6 months of fingolimod treatment in patients with multiple sclerosis (2024) Hilz MJ, Canavese F, de Rojas Leal C, Lee DH, Linker RA, Wang R Journal article Transoral laser microsurgery for supraglottic carcinomas: results of a prospective multicenter trial (SUPRATOL) (2024) Ambrosch P, Meuret S, Dietz A, Fazel A, Fietkau R, Tostmann R, Schroeder U, et al. Journal article Cognition in patients with myelin oligodendrocyte glycoprotein antibody-associated disease: a prospective, longitudinal, multicentre study of 113 patients (CogniMOG-Study) (2024) Passoke S, Stern C, Häußler V, Kümpfel T, Havla J, Engels D, Jarius S, et al. Journal article De-intensification of postoperative radiotherapy in head and neck cancer irrespective of human papillomavirus status—results of a prospective multicenter phase II trial (DIREKHT Trial) (2024) Haderlein M, von der Grün J, Balermpas P, Rödel C, Hautmann MG, Steger F, Bohr C, et al. Journal article